There are other FDA-approved weight-loss drugs with similar mechanisms
Mounjaros dual action on both GLP-1 and GIP receptors enhances its ability to control blood sugar, often leading to better outcomes than older medications
Research news A University of Texas at El Paso study has found that people with type 2 diabetes or obesity who used glucagon-like peptide-1 receptor agonists had lower odds of alcohol, opioid, nicotine and cocaine use disorders, although researchers said clinical trials were needed before the drugs could be considered for addiction treatment A study led by researchers at The University of Texas at El Paso, USA, has found that the use of diabetes and weight loss medicines such as Ozempic was associated with a lower risk of alcohol, opioid, nicotine and cocaine use disorders
The other halfactually changing those eating habitsis what a pro weight-loss coach specializes in
In 2025, consumers are no longer satisfied with generic advice or algorithm-driven diet apps - they want frameworks grounded in clinical logic, user-specific feedback loops, and systems that can adapt to fluctuating physiological and behavioral conditions